| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, Chief Commercial Officer
2 companies
Jeffrey Robert Ajer is EVP, Chief Commercial Officer at BMRN, with reported holdings spanning 2 companies. From June 2016 to September 2026, the filings on record show 0 open-market purchases and 46 sales. Jeffrey Robert Ajer's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.9M at current prices.
Our model assigns Jeffrey Robert Ajer a middling insider score of 58/100, based on 20 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of +0.3%.
Jeffrey Robert Ajer's largest disclosed position is in BMRN as EVP, Chief Commercial Officer, worth about $3.7M. The BMRN filings lean toward selling, a net 187,144 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sale+OE | 9,000 | $92.15 | $829,358.84 | -15.5% | |
| Oct 3, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 1,000 | $98.98 | $98,984.80 | -2.0% | |
| Sep 20, 2018 | NKTR Nektar Therapeutics | Director | Sell | 6,750 | $56.76 | $383,130.00 | -30.0% | |
| Jun 11, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 1,436 | $90.31 | $129,685.16 | -2.8% | |
| May 7, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 309 | $85.96 | $26,561.64 | -0.6% | |
| Apr 2, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 2,119 | $80.12 | $169,774.28 | -3.9% | |
| Mar 29, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 1,537 | $79.69 | $122,483.53 | -2.7% | |
| Mar 21, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 4,368 | $83.90 | $366,475.20 | -6.8% | |
| Mar 9, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sell | 2,972 | $82.39 | $244,863.08 | -5.1% | |
| Sep 22, 2017 | BMRN Biomarin Pharmaceutical Inc | EVP, Chief Commercial Officer | Sale+OE | 3,521 | $95.00 | $334,495.00 | -6.8% |